The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
Open accessAbstract
Human clinical trials in type 1 diabetes (T1D) patients using mesenchymal stem cells (MSC) are presently underway without prior validation in a mouse model for the disease. In response to this void, we characterized bone marrow-derived murine MSC for their ability to modulate immune responses in the context of T1D, as represented in NOD mice. In comparison to NOD mice, BALB/c-MSC mice were found to express higher levels of the negative costimulatory molecule PD-L1 and to promote a shift toward Th2-like responses in treated NOD mice. In addition, transfer of MSC from resistant strains (i.e., nonobese resistant mice or BALB/c), but not from NOD mice, delayed the onset of diabetes when administered to prediabetic NOD mice. The number of BALB/c-MSC trafficking to the pancreatic lymph nodes of NOD mice was higher than in NOD mice provided autologous NOD-MSC. Administration of BALB/c-MSC temporarily resulted in reversal of hyperglycemia in 90% of NOD mice (p = 0.002). Transfer of autologous NOD-MSC imparted no such therapeutic benefit. We also noted soft tissue and visceral tumors in NOD-MSC-treated mice, which were uniquely observed in this setting (i.e., no tumors were present with BALB/c- or nonobese resistant mice-MSC transfer). The importance of this observation remains to be explored in humans, as inbred mice such as NOD may be more susceptible to tumor formation. These data provide important preclinical data supporting the basis for further development of allogeneic MSC-based therapies for T1D and, potentially, for other autoimmune disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., et al. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00769-x · Cited by 2,295
Osteogenesis in transplants of bone marrow cells
Friedenstein, A. J., Piatetzky-Shapiro, I. I., & Petrakova, K. V. (1966) · Development · doi:10.1242/dev.16.3.381 · Cited by 1,671
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1496 · Cited by 1,430
Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro
Oswald, J., Boxberger, S., Jørgensen, B., Feldmann, S., Ehninger, G., Bornhäuser, M., & Werner, C. (2004) · STEM CELLS · doi:10.1634/stemcells.22-3-377 · Cited by 1,317
Tissue expression of PD-L1 mediates peripheral T cell tolerance
Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051776 · Cited by 1,211
Self-citationImmunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lönnies, H., Marschall, H.-U., Dlugosz, A., Szakos, A., Hassan, Z., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000214462.63943.14 · Cited by 1,142
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
Ansari, M. J. I., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022125 · Cited by 814
Self-citationImmunomodulation by mesenchymal stem cells and clinical experience
Le Blanc, K., & Ringdén, O. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01844.x · Cited by 720
Mesenchymal stem cells avoid allogeneic rejection
Ryan, J. M., Barry, F. P., Murphy, J. M., & Mahon, B. P. (2005) · Journal of Inflammation · doi:10.1186/1476-9255-2-8 · Cited by 714
Augello, A., Tasso, R., Negrini, S. M., Amateis, A., Indiveri, F., Cancedda, R., & Pennesi, G. (2005) · European Journal of Immunology · doi:10.1002/eji.200425405 · Cited by 696
Self-citationNauta, A. J., Westerhuis, G., Kruisselbrink, A. B., Lurvink, E. G. A., Willemze, R., & Fibbe, W. E. (2006) · Blood · doi:10.1182/blood-2005-11-011650 · Cited by 694
Koç, O., Day, J., Nieder, M., Gerson, S., Lazarus, H., & Krivit, W. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703650 · Cited by 652
Sackstein, R., Merzaban, J. S., Cain, D. W., Dagia, N. M., Spencer, J. A., Lin, C. P., & Wohlgemuth, R. (2008) · Nature Medicine · doi:10.1038/nm1703 · Cited by 641
Sarcoma Derived from Cultured Mesenchymal Stem Cells
Tolar, J., Nauta, A. J., Osborn, M. J., Panoskaltsis Mortari, A., McElmurry, R. T., Bell, S., Xia, L., Zhou, N., Riddle, M., Schroeder, T. M., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2005-0620 · Cited by 639
Augello, A., Tasso, R., Negrini, S. M., Cancedda, R., & Pennesi, G. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22511 · Cited by 587
Self-citationImmunomodulation by Mesenchymal Stem Cells
Abdi, R., Fiorina, P., Adra, C. N., Atkinson, M., & Sayegh, M. H. (2008) · Diabetes · doi:10.2337/db08-0180 · Cited by 463
Self-citationGonzalez-Rey, E., Gonzalez, M. A., Varela, N., O'Valle, F., Hernandez-Cortes, P., Rico, L., Büscher, D., & Delgado, M. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101881 · Cited by 426
Casiraghi, F., Azzollini, N., Cassis, P., Imberti, B., Morigi, M., Cugini, D., Cavinato, R. A., Todeschini, M., Solini, S., Sonzogni, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3933 · Cited by 423
Tarbell, K. V., Petit, L., Zuo, X., Toy, P., Luo, X., Mqadmi, A., Yang, H., Suthanthiran, M., Mojsov, S., & Steinman, R. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061631 · Cited by 342
Pancreatic Lymph Nodes Are Required for Priming of β Cell Reactive T Cells in NOD Mice
Gagnerault, M.-C., Luan, J. J., Lotton, C., & Lepault, F. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011353 · Cited by 295
Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells
Chen, L.-B. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i20.3016 · Cited by 295
Type 1 diabetes as a relapsing–remitting disease?
von Herrath, M., Sanda, S., & Herold, K. (2007) · Nature Reviews Immunology · doi:10.1038/nri2192 · Cited by 270
Tian, J., Clere-Salzler, M., Herschenfeld, A., Middleton, B., Newman, D., Mueller, R., Arita, S., Evans, C., Atkinson, M. A., Mullen, Y., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1348 · Cited by 259
Self-citationKassis, I., Zangi, L., Rivkin, R., Levdansky, L., Samuel, S., Marx, G., & Gorodetsky, R. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705358 · Cited by 239
Mesenchymal stem cells: properties and role in clinical bone marrow transplantation
Le Blanc, K., & Ringdén, O. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.07.004 · Cited by 221
Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis
Mazzini, L., Mareschi, K., Ferrero, I., Vassallo, E., Oliveri, G., Boccaletti, R., Testa, L., Livigni, S., & Fagioli, F. (2006) · Neurological Research · doi:10.1179/016164106x116791 · Cited by 200
Bocelli-Tyndall, C., Bracci, L., Spagnoli, G., Braccini, A., Bouchenaki, M., Ceredig, R., Pistoia, V., Martin, I., & Tyndall, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kel267 · Cited by 193
NOR/Lt Mice: MHC-Matched Diabetes-Resistant Control Strain for NOD Mice
Procházka, M., SERREZE, D. V., Frankel, W. N., & Leiter, E. H. (1992) · Diabetes · doi:10.2337/diab.41.1.98 · Cited by 154
Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
Fiorina, P., Vergani, A., Dada, S., Jurewicz, M. M., Wong, M., Law, K., Wu, E., Tian, Z., Abdi, R., Guleria, I., et al. (2008) · Diabetes · doi:10.2337/db08-0420 · Cited by 144
Self-citationChamberlain, G., Wright, K. T., Rot, A., Ashton, B. A., & Middleton, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002934 · Cited by 121
Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient
Christen, U., Benke, D., Wolfe, T., Rodrigo, E., Rhode, A., Hughes, A. C., Oldstone, M. B. A., & von Herrath, M. G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17005 · Cited by 116
Engineering mesenchymal stem cells for immunotherapy
Jørgensen, C., Djouad, F., Apparailly, F., & Noël, D. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302019 · Cited by 105
Numaguchi, Y., Sone, T., Okumura, K., Ishii, M., Morita, Y., Kubota, R., Yokouchi, K., Imai, H., Harada, M., Osanai, H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.000588 · Cited by 104
Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny
Behfar, A., & Terzic, A. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0429 · Cited by 70
Tonkin, D. R., He, J., Barbour, G., & HASKINS, K. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4516 · Cited by 69
Type I (Insulin-Dependent) Diabetes Is a Th1- and Th2-Mediated Autoimmune Disease
Azar, S. T., Tamim, H., Beyhum, H. N., Habbal, Z., & Almawi, W. Y. (1999) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.3.306-310.1999 · Cited by 60
15 Immunomodulation by mesenchymal stem cells – a potential therapeutic strategy for type 1 diabetes
Mounayar, M., Magee, C. N., & Abdi, R. (2013) · De Gruyter eBooks · doi:10.1515/9783110298307.309 · Cited by 51
Self-citationImbalance in Th Cell Polarization and its Relevance in Type 1 Diabetes Mellitus
Sia, C. (2005) · The Review of Diabetic Studies · doi:10.1900/rds.2005.2.182 · Cited by 47
Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice.
Chiu, P., Ivakine, E. A., Mortin-Toth, S. M., & Danska, J. S. (2002) · PubMed · Cited by 34
Why Can’t We Prevent Type 1 Diabetes?
Schatz, D., Gale, E. A., & Atkinson, M. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3326 · Cited by 31
Self-citationMechanisms of Immunomodulation by Mesenchymal Stem Cells
Ozaki, K., Sato, K., Oh, I., Meguro, A., Tatara, R., Muroi, K., & Ozawa, K. (2007) · International Journal of Hematology · doi:10.1532/ijh97.07003 · Cited by 31
Mesenchymal stem cells and rheumatoid arthritis
Jørgensen, C., Djouad, F., Fritz, V., Apparailly, F., Louis‐Plence, P., & Noël, D. (2003) · Joint Bone Spine · doi:10.1016/j.jbspin.2003.08.001 · Cited by 27
Cited by
Mesenchymal Stem Cells: Mechanisms of Inflammation
Singer, N. G., & Caplan, A. I. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130230 · Cited by 851
Immunobiology of mesenchymal stem cells
Ma, S., Xie, N., Li, W., Yuan, B., Shi, Y., & Wang, Y. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.158 · Cited by 771
Mesenchymal Stem Cells as Therapeutics
Parekkadan, B., & Milwid, J. M. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105309 · Cited by 759
Weiss, A. R. R., & Dahlke, M. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01191 · Cited by 695
How mesenchymal stem cells interact with tissue immune responses
Shi, Y., Su, J., Roberts, A. I., Shou, P., Rabson, A. B., & Ren, G. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.11.004 · Cited by 633
Metadata
- Authors
- Fiorina, P., Jurewicz, M., Augello, A., Vergani, A., Dada, S., La Rosa, S., Selig, M., Godwin, J., Law, K., Placidi, C., Smith, R. N., Capella, C., Rodig, S., Adra, C. N., Atkinson, M., Sayegh, M. H., & Abdi, R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07
- Volume
- 183
- Issue
- 2
- Pages
- 993-1004
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1510928501
- Cited by
- 381
- References
- 47
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.